Allurion
allurion.com
Actively hiring
Lifestyle
Weight Management
Fitness
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Runway Growth Capital
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 23
Certified Allurion Receives U.S. FDA Approval · businesswire
Backed byfrom the funds' portfolios and accelerator catalogs
Runway Growth Capital Similar startupsby what they do, their industry and backers
Calibrate is a metabolic health company that is revolutionizing the approach to weight management. Our mission is to change the way the…
Second Nature combines weight loss medication, dietitian coaching, and behaviour change support. NHS-trusted, CQC-regulated care for…
Simple is your key to long term weight loss and well-being. Learn to eat healthy, fast safely, and move & hydrate more with practical…
Premium solutions for weight loss, PCOS, skin, mood, protein & more. Winner of Forbes 30U30, ET Best Brands For Women, Vogue Wellness…
Get prescription GLP-1 medications — Ozempic, Wegovy, Zepbound, Mounjaro — online. Personalized weight loss plans with licensed providers…
Physician-led 12-week programs for type 2 diabetes, weight loss, and chronic conditions. Free with your provincial health card in BC…
News
Allurion Receives U.S. FDA Approval
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) ha...
Read more
Report
Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025
NATICK, Mass., August 07, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that it will report financial results for the second quarter 2025 on Wednesday, August
Read more
Report
Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025
Read more
Report
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
Allurion Technologies, Inc., a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence. 52 patients treated with the Allurion B
Read more
Report
- Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
Allurion Technologies, Inc., a company dedicated to ending obesity, today announced that it will report financial results for the second quarter 2024 on Tuesday, August 13, 2024. Company management will host a conference call to discuss financial results
Read more
Report
Allurion balloon promises weight loss similar to popular drugs. How does it work?
It's billed as an alternative for people with obesity who don't want bariatric surgery or weight-loss drugs. But does it get the same long-term results?
Read more
Report
Show more news